BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 18565617)

  • 21. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.
    De Waele M; Hendriks J; Lauwers P; Ortmanns P; Vanroelen W; Morel AM; Germonpré P; Van Schil P
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):240-3. PubMed ID: 16386916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment.
    Lee JG; Lee CY; Kim DJ; Chung KY; Park IK
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):480-4. PubMed ID: 18249000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T; Dienemann H; Ebert W
    Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
    Christian C; Erica S; Morandi U
    Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
    Song LH; Song XR; Liu MQ; Zhang XQ; Zheng L; Li XJ; Liu PX
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):345-8. PubMed ID: 15312344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
    Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
    Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.
    Pfannschmidt J; Muley T; Bülzebruck H; Hoffmann H; Dienemann H
    Lung Cancer; 2007 Mar; 55(3):371-7. PubMed ID: 17123661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer.
    Lavolé A; Chouaïd C; Baudrin L; Wislez M; Raguin G; Pialoux G; Girard PM; Milleron B; Cadranel J
    Lung Cancer; 2009 Sep; 65(3):345-50. PubMed ID: 19135758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.
    Ichinose Y; Hara N; Ohta M; Yano T; Maeda K; Asoh H; Katsuda Y
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):90-4. PubMed ID: 8391613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
    Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
    Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery.
    Flannery TW; Suntharalingam M; Regine WF; Chin LS; Krasna MJ; Shehata MK; Edelman MJ; Kremer M; Patchell RA; Kwok Y
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):19-23. PubMed ID: 18280058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system.
    Oliaro A; Filosso PL; Cavallo A; Giobbe R; Mossetti C; Lyberis P; Cristofori RC; Ruffini E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):438-43; discussion 443. PubMed ID: 18502660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of pneumonectomy for non-small cell lung cancer: appropriateness of the new TNM staging system.
    Mizushima Y; Noto H; Kusajima Y; Sugiyama S; Yamashita R; Sassa K; Kobayashi M
    Oncol Rep; 1998; 5(2):437-40. PubMed ID: 9468575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
    Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC
    J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy.
    d'Amato TA; Pettiford BL; Schuchert MJ; Parker R; Ricketts WA; Luketich JD; Landreneau RJ
    Ann Surg Oncol; 2009 Oct; 16(10):2848-55. PubMed ID: 19609620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental state as a possible independent prognostic variable for survival in patients with advanced lung carcinoma.
    Nakahara Y; Mochizuki Y; Miyamoto Y; Tanaka A; Kawamura T; Sasaki S; Nakahara Y; Katsura Y
    Cancer; 2002 Jun; 94(11):3006-15. PubMed ID: 12115391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
    Mandrekar SJ; Schild SE; Hillman SL; Allen KL; Marks RS; Mailliard JA; Krook JE; Maksymiuk AW; Chansky K; Kelly K; Adjei AA; Jett JR
    Cancer; 2006 Aug; 107(4):781-92. PubMed ID: 16847887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.